Citation Impact
Citing Papers
Cancer statistics, 2022
2022 Standout
Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
1999
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Cancer statistics, 2023
2023 Standout
Guidelines for the welfare and use of animals in cancer research
2010 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Cancer statistics, 2024
2024 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
PET in oncology: Will it replace the other modalities?
1997
Molecular imaging in drug development
2008 Standout
Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis
2011
Guidelines for radioiodine therapy of differentiated thyroid cancer
2008
Monitoring response to therapy in cancer using [ 18 F]-2-fluoro-2-deoxy- d -glucose and positron emission tomography: an overview of different analytical methods
2000
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Thyroid cancer
2016 Standout
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
2001 Standout
Optimal timing of surgery in well-differentiated thyroid carcinoma detected during pregnancy
2005
Outcomes Following Thyroid and Parathyroid Surgery in Pregnant Women
2009
Minimally Invasive Pharmacokinetic and Pharmacodynamic Technologies in Hypothesis-Testing Clinical Trials of Innovative Therapies
2006
Role of SPECT/CT in differentiated thyroid cancer
2012
Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality
2003 Standout
Monitoring chemotherapy and radiotherapy of solid tumors
2006
[18F]FDG PET monitoring of tumour response to chemotherapy: does [18F]FDG uptake correlate with the viable tumour cell fraction?
2003
Cushing's syndrome
2015 Standout
Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation
2009
Esophageal Cancer
2003 Standout
Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer
2011
131I SPECT/CT in the Follow-up of Differentiated Thyroid Carcinoma: Incremental Value Versus Planar Imaging
2009
Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma – A systematic review
2015
The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging
2010
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Thyroid Imaging Reporting and Data System for US Features of Nodules: A Step in Establishing Better Stratification of Cancer Risk
2011 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin.
2002
Thyroid cancer in toxic and non-toxic multinodular goiter
2007
A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors
2008
Testicular germ-cell tumours in a broader perspective
2005 Standout
Thyroid cancer in pregnancy
2005
Preparation with Recombinant Human Thyroid-Stimulating Hormone for Thyroid Remnant Ablation with 131I Is Associated with Lowered Radiotoxicity
2008
Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]‐2‐fluro‐2‐deoxy‐d ‐glucose positron emission tomography
2008
Clinical role of positron emission tomography in oncology
2001
Dosimetry and thyroid cancer: the individual dosage of radioiodine
2010
Radioiodine Treatment for Differentiated Thyroid Cancer
2000
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
Use of Radioactive Iodine for Thyroid Cancer
2011
Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging The Visual Response Score and the Change in Total Lesion Glycolysis
1999
Germ Cell Tumor: Differentiation of Viable Tumor, Mature Teratoma, and Necrotic Tissue with FDG PET and Kinetic Modeling
1999
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
Cancer treatment and survivorship statistics, 2012
2012 Standout
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [18F]FDG PET
2002
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
1999
Extent of Surgery Affects Survival for Papillary Thyroid Cancer
2007 Standout
A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors
2007
Differentiated thyroid carcinoma in childhood and adolescence—clinical course and role of radioiodine
2003
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Testicular function after 131I therapy for hyperthyroidism
2006
The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0
2012
Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
1998
Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment
2004
Incremental Diagnostic Value of SPECT/CT with131I Scintigraphy after Radioiodine Therapy in Patients with Well-differentiated Thyroid Carcinoma
2012
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy
2008
Integrating cell-signalling pathways with NF-κB and IKK function
2006 Standout
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Radioactive Iodine and the Salivary Glands
2003
The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
2009
Impact of Pregnancy on Serum Thyroglobulin and Detection of Recurrent Disease Shortly After Delivery in Thyroid Cancer Survivors
2007
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Testicular Function After Radioiodine Therapy in Patients with Thyroid Cancer
2006
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Screening for Thyroid Cancer
2017
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Whole Body 18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial
2003
The Effect of Pregnancy on Thyroid Nodule Formation
2002
Revised Response Criteria for Malignant Lymphoma
2007 Standout
Positron Emission Tomography Using [18F]-Fluorodeoxy-d -Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy
2000
Complications of Radioactive Iodine Treatment of Thyroid Carcinoma
2010
Positron Emission Tomography As an Imaging Biomarker
2006
Screening for Colorectal Cancer
2016 Standout
Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
2005
Papillary Microcarcinoma
2008
Positron-Emission Tomography and Assessment of Cancer Therapy
2006
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2007
Therapeutic Sialendoscopy for the Management of Radioiodine Sialadenitis
2012
Cancer treatment and survivorship statistics, 2016
2016 Standout
Prediction of Response to Preoperative Chemotherapy in Gastric Carcinoma by Metabolic Imaging: Results of a Prospective Trial
2003
Cancer treatment and survivorship statistics, 2019
2019 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases
2009
Thyroid Function and Human Reproductive Health
2010
The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings
2003
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Guidelines for the management of thyroid cancer
2014 Standout
Putting the Rap on Akt
2004
Optimal Timing of Surgery for Differentiated Thyroid Cancer in Pregnant Women
2013
Prognosis of small thyroid cancer in patients with Graves' disease
2006
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
2005
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging
2001
Dynamic imaging of transient metabolic processes by small-animal PET for the evaluation of photosensitizers in photodynamic therapy of cancer.
2006
Thyroid carcinoma
2003 Standout
Cancer treatment and survivorship statistics, 2014
2014 Standout
Screening for Thyroid Cancer
2017
Works of B. Pratt being referenced
Optimization of Equipment and Methodology for Whole Body Activity Retention Measurements in Children Undergoing Targeted Radionuclide Therapy
2007
Thyroid volume measurement in thyrotoxic patients: comparison between ultrasonography and iodine-124 positron emission tomography
1997
Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.
1996
Salivary Gland Toxicity after Radioiodine Therapy for Thyroid Cancer
2006
False positive 131I whole body scans in thyroid cancer.
2000
Management of differentiated thyroid cancer diagnosed during pregnancy
1999
Imaging metastatic testicular germ cell tumours with18FDG positron emission tomography: prospects for detection and management
1995
Testicular dose and fertility in men following I131 therapy for thyroid cancer
2002
Good prognosis in thyroid cancer found incidentally at surgery for thyrotoxicosis
1999
Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer
2002